Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2021
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2020
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [3]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NMD Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Zero Leprosy Toolkit
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Preventive Chemotherapy (PC)

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (100)
  • Lymphatic filariasis (Elephantiasis) (3)
  • Onchocerciasis (3)
  • Trachoma (2)
  • Schistosomiasis (1)
  • Soil-transmitted helminths (1)
  • Yaws (1)

Subject

  • (-) Preventive Chemotherapy (PC) (110)
  • Prevention of disease (31)
  • SDR-PEP (29)
  • Contacts / Contact tracing (28)
  • Immunoprophylaxis / Vaccine (28)
  • Multi-drug therapy (MDT) (11)
  • Transmission (11)
  • Neglected tropical diseases (NTDs) (7)
  • Rifampicin - RMP (7)
  • Complications and reactions (5)
  • Epidemiology (5)
  • Drug resistance (5)
  • Diagnosis (4)
  • Treatment (4)
  • Children (3)
  • Disability (3)
  • Diagnostic tests (3)
  • Mycobacterium indicus pranii (MIP) (3)
  • Moxifloxacin (3)
  • Clarithromycin - CLARI (3)
  • Mass Drug Administration (MDA) (3)
  • Skin related NTDs (2)
  • Stigma (leprosy related) (2)
  • Case detection (2)
  • Management of disease complication (2)
  • Tuberculosis (2)
  • Rifapentine - RPT (2)
  • Geographic Information Systems (GIS) & Mapping (2)
  • Stigma (2)
  • Uniform multi-drug therapy (U-MDT) (1)
  • Mental health (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (1)
  • Nerve function impairment (NFI) (1)
  • Digital health interventions (1)
  • WASH (1)
  • Environmental conditions (1)
  • HIV/AIDS (1)
  • Disability grading (1)
  • Health systems factors (1)
  • Poverty (1)
  • Global leprosy situation (1)
  • Ofloxacin - OFLO (1)
  • Reversal reaction (Type 1 reaction) (1)
  • Evidence of effectiveness (1)
  • Dapsone (1)
  • Health education (1)
  • One Health (1)

Publication Type

  • Article (95)
  • Book (2)
  • Chapter (1)
  • Dissertation / Thesis (3)
  • Full text online (78)
  • Global leprosy strategy (2)
  • How-to / Guidelines (1)
  • Intervention study (1)
  • Report (4)
  • Systematic review (7)
  • TAG report (1)
  • WHO publication (5)

Author/Contributor

  • Richardus JH (17)
  • Mieras L (8)
  • Noordeen S K (6)
  • van Brakel WH (5)
  • Oskam L (5)
  • Neelan P N (5)
  • Lockwood DN (4)
  • Pahan D (4)
  • Steinmann P (4)
  • LPEP study group (3)
  • Cavaliero A (3)
  • Richardus J H (3)
  • Cartel J L (3)
  • Mukherjee A (3)
  • Grosset J H (3)
  • Mukherjee R (3)
  • Kar H K (3)
  • Richardus R (3)
  • Plichart R (2)
  • Moet JF (2)
  • Ebenezer M (2)
  • Alam K (2)
  • Sivaprasad N (2)
  • Otsyula Y (2)
  • Feenstra SG (2)
  • Ponnaiya J (2)
  • Tiwari A (2)
  • Yonekura T (2)
  • Takahashi J (2)
  • Soares CB (2)
  • Kasang C (2)
  • Tiwari A (2)
  • Mirza F (2)
  • Steinmann P (2)
  • Gillini L (2)
  • Chanteau S (2)
  • Arif M (2)
  • Boutin J P (2)
  • Saunderson P (2)
  • Das M (2)
  • Krishnamurthy P (2)
  • Cambau E (2)
  • World Health Organization (2)
  • Ignotti E (2)
  • Rodrigues LC (2)
  • Sarno EN (2)
  • Geluk A (2)
  • Sales AM (2)
  • Penna G (2)
  • Kumar B (2)
  • Oskam L (2)
  • Katoch K (2)
  • Zaheer S A (2)
  • Kaur H (2)
  • Talwar G P (2)
  • Joseph P (2)
  • Arumugam S (2)
  • Misra R S (2)
  • Abalos R M (2)
  • Fajardo T T (2)
  • Cellona R V (2)
  • Krahenbuhl J L (1)
  • Virmond M (1)
  • Klatser P R (1)
  • Sehgal V N (1)
  • Katoch V M (1)
  • Narang T (1)
  • Katoch K (1)
  • Richard J (1)
  • Kaur I (1)
  • Kumar B (1)
  • Ito T (1)
  • Manglani P R (1)
  • Vijayakumaran P (1)
  • Sharma VD (1)
  • Katoch VM (1)
  • Natrajan M (1)
  • Bierrenbach AL (1)
  • Gillis T P (1)
  • Pahan D (1)
  • Penna GO (1)
  • Rodríguez del Valle KM (1)
  • Leiker DL (1)
  • WHO/Department of control of neglected tropical diseases (1)
  • Sardana K (1)
  • Walker SL (1)
  • Reed SG (1)
  • Duthie MS (1)
  • Taal AT (1)
  • Schuring RP (1)
  • Costa Nery JA (1)
  • Smith W C (1)
  • Ferreira SMB (1)
  • Moraes MO (1)
  • Klatser PR (1)
  • Ignotti E (1)
  • Duppre NC (1)
  • Scollard D M (1)
  • Menezes VM (1)
  • Kaur I (1)

Journal

  • Acta leprologica (1)
  • Anais brasileiros de dermatologia (1)
  • An Bras Dermatol (1)
  • Annals of tropical medicine and public health (1)
  • BMC health services research (1)
  • BMC infectious diseases (4)
  • BMC Infectious Diseases (1)
  • BMJ (Clinical research ed.) (1)
  • BMJ open (1)
  • British medical journal (1)
  • Cadernos de saude publica (1)
  • Clinical and diagnostic laboratory immunology (1)
  • Clinical microbiology reviews (1)
  • Clinics in Dermatology (1)
  • Community skin health (1)
  • Devex (1)
  • European Journal of Molecular & Clinical Medicine (1)
  • Indian journal of dermatology, venereology and leprology (3)
  • Indian journal of leprosy (5)
  • Infectious Diseases of Poverty (1)
  • Infectious diseases of poverty (1)
  • International Journal of Contemporary Pediatrics (1)
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (3)
  • International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association (6)
  • JAMA: The Journal of the American Medical Association (1)
  • JBI database of systematic reviews and implementation reports (2)
  • Journal of the American Academy of Dermatology (1)
  • Jurnal Widya Medika (1)
  • Leiden University of Medical Center (1)
  • Leprosy in India (3)
  • Leprosy review (20)
  • Nucleic acids research (1)
  • PLoS neglected tropical diseases (8)
  • PLOS Neglected Tropical Diseases (1)
  • Research and Reports in Tropical Medicine (1)
  • Revista brasileira de leprologia (1)
  • Revista de leprologia (1)
  • Revista do Instituto de Medicina Tropical de Sao Paulo (1)
  • Revista panamericana de salud publica = Pan American journal of public health (1)
  • Risk management and healthcare policy (1)
  • Skin Disorders in Vulnerable Populations (1)
  • The American journal of tropical medicine and hygiene (1)
  • The Indian journal of medical research (2)
  • The Journal of infection (1)
  • The Journal of infectious diseases (1)
  • The Lancet. Global health (1)
  • The Lancet. Infectious diseases (2)
  • Trials (1)
  • University of Liverpool (1)
  • Vaccine (2)

Year of Publication

  • 2021 (34)
  • 2020 (1362)
  • 2019 (1198)
  • 2018 (1170)
  • 2017 (1239)
  • 2016 (1373)
  • 2015 (1068)
  • 2014 (893)
  • 2013 (854)
  • 2012 (652)
  • 2011 (597)
  • 2010 (562)
  • 2009 (589)
  • 2008 (550)
  • 2007 (460)
  • 2006 (443)
  • 2005 (443)
  • 2004 (480)
  • 2003 (463)
  • 2002 (389)
  • 2001 (394)
  • 2000 (428)
  • 1999 (443)
  • 1998 (452)
  • 1997 (419)
  • 1996 (412)
  • 1995 (454)
  • 1994 (493)
  • 1993 (477)
  • 1992 (501)
  • 1991 (490)
  • 1990 (511)
  • 1989 (529)
  • 1988 (552)
  • 1987 (504)
  • 1986 (551)
  • 1985 (523)
  • 1984 (496)
  • 1983 (547)
  • 1982 (500)
  • 1981 (440)
  • 1980 (391)
  • 1979 (422)
  • 1978 (347)
  • 1977 (308)
  • 1976 (398)
  • 1975 (331)
  • 1974 (350)
  • 1973 (342)
  • 1972 (315)
  • 1971 (336)
  • 1970 (314)
  • 1969 (286)
  • 1968 (318)
  • 1967 (260)
  • 1966 (281)
  • 1965 (254)
  • 1964 (193)
  • 1963 (145)
  • 1962 (140)
  • 1961 (154)
  • 1960 (175)
  • 1959 (140)
  • 1958 (129)
  • 1957 (168)
  • 1956 (161)
  • 1955 (148)
  • 1954 (147)
  • 1953 (187)
  • 1952 (227)
  • 1951 (205)
  • 1950 (160)
  • 1949 (43)
  • 1948 (88)
  • 1947 (78)
  • 1946 (36)
  • 1945 (9)
  • 1944 (2)
  • 1942 (5)
  • 1941 (1)
  • 1940 (6)
  • 1939 (8)
  • 1938 (8)
  • 1937 (7)
  • 1936 (24)
  • 1935 (6)
  • 1934 (12)
  • 1933 (12)
  • 1932 (7)
  • 1931 (6)
  • 1930 (7)
  • 1929 (11)
  • 1928 (2)
  • 1927 (6)
  • 1926 (8)
  • 1925 (9)
  • 1924 (8)
  • 1923 (2)
  • 1922 (4)
  • 1921 (2)
  • 1920 (4)
  • 1919 (1)
  • 1917 (1)
  • 1916 (2)
  • 1915 (4)
  • 1914 (6)
  • 1913 (2)
  • 1912 (4)
  • 1911 (11)
  • 1910 (6)
  • 1909 (5)
  • 1908 (4)
  • 1907 (1)
  • 1906 (3)
  • 1905 (1)
  • 1904 (4)
  • 1903 (1)
  • 1902 (5)
  • 1901 (2)
  • 1899 (1)
  • 1898 (4)
  • 1897 (4)
  • 1896 (1)
  • 1895 (2)
  • 1893 (2)
  • 1892 (3)
  • 1891 (2)
  • 1890 (7)
  • 1889 (9)
  • 1888 (1)
  • 1886 (1)
  • 1883 (1)
  • 1881 (1)
  • 1880 (1)
  • 1879 (3)
  • 1878 (1)
  • 1877 (3)
  • 1876 (2)
  • 1875 (3)
  • 1874 (1)
  • 1873 (1)
  • 1872 (1)
  • 1870 (4)
  • 1868 (1)
  • 1867 (1)
  • 1866 (1)
  • 1864 (1)
  • 1863 (1)
  • 1861 (1)
  • 1857 (1)
  • 1855 (1)
  • 1847 (1)
  • 1800 (1)
  • 1765 (1)
  • 2 (1)
  • 0 (153)

Language

  • English (101)
  • Portuguese (2)
  • Spanish (1)

Regional focus

  • African Region (AFR) (10)
    • Comoros (2)
    • Kenya (1)
    • Madagascar (1)
    • Sierra Leone (1)
    • Tanzania (3)
    • Uganda (1)
  • Eastern Mediterranean Region (EMR) (2)
    • Morocco (1)
  • European Region (EUR) (3)
    • Netherlands (1)
  • Region of the Americas (AMR) (16)
    • Brazil (13)
    • Cuba (1)
  • South-East Asia Region (SEAR) (22)
    • Bangladesh (6)
    • India (10)
    • Indonesia (9)
    • Myanmar (3)
    • Nepal (4)
    • Sri Lanka (3)
    • Thailand (1)
  • Western Pacific Region (WPR) (15)
    • Cambodia (4)
    • French Polynesia (3)
    • Kiribati (2)
    • Korea, South – Republic of Korea (1)
    • Micronesia, Federated States of (1)
    • Philippines (3)

Research Group

  • LRI / Leprosy Research Initiative
  • IDEAL
  • EUR / Field evaluation of novel immunodiagnostic tools (Jan 2015- Dec 2018)
  • SARI Project (2010-2016)
  • KIT / Treatment of Early Neuropathy in Leprosy Trial (TENLEP) (2010-2016)
  • LSHTM / Development & validation severity scale ENL May 2015 - April 2017
  • IDRI / Integration of rapid diagnostic tests to facilitate case management of leprosy (May 2015 - April 2019)
  • AMC / Role of complement system in nerve damage (2011-2014)
  • LUMC / Immunopathology of leprosy, follow up (2011-2015)
  • Enablement / Inclusion of people with physical disabilities in Nepal
  • LWM / Macro and micro epidemiology of leprosy in Cebu
 
Relevance
Date
110 items

Publication

Leprosy post-exposure prophylaxis: innovation and precision public health.

Moraes M, Düppre N. The Lancet. Global health. 2021; 9 (1) : e8-e9.
Download PDF

Publication

A Systematic Review of the Importance of Chemoprophylaxis and Immunoprophylaxis in Subclinical Case of Leprosy that can Reduce the Incidence and the Transmission of Leprosy

Mulianto N, Sari ADAP, Kariosentono H, et al. European Journal of Molecular & Clinical Medicine. 2020; 7 (11) : 709-715.
Download PDF

Publication

Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030: Report of the virtual meeting 26-30 October 2020

WHO/Department of control of neglected tropical diseases . World Health Organization. 2020;
Download PDF

Publication

Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis

World Health Organization . World Health Organization. 2020;
Download PDF

Publication

ENDING the NEGLECT to ATTAIN the SUSTAINABLE DEVELOPMENT GOALS - A road map for neglected tropical diseases 2021–2030

World Health Organization . World Health Organization. 2020;
Download PDF

Publication

A comprehensive research agenda for zero leprosy

Steinmann P, Dusenbury C, Addiss D, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2020;
Download PDF

Publication

The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis

Schoenmakers A, Mieras L, Budiawan T, et al. Informa UK Limited. Research and Reports in Tropical Medicine. 2020;
Download PDF

Publication

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.

Lenz S, Collins J, Ray N, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008583.
Download PDF

Publication

Jopling's Handbook of Leprosy, 6/E

Sardana K, Khurana A. CBS Publishers & Distributors. 2020;
Download PDF

Publication

CHEMOPROPHYLAXIS VERSUS IMMUNOPROPHYLAXIS IN TUBERCULOSIS AND LEPROSY INFECTION

Novita BD. Jurnal Widya Medika. 2020; 6 (1) : 65-71.

Publication

Report of the first meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases

World Health Organization (WHO) . World Health Organization. 2020;
Download PDF

Publication

Potential Public Health Measures to Tackle Skin Diseases

Mphande FA. Springer Singapore. Skin Disorders in Vulnerable Populations. 2020;

Publication

Leprosy: Treatment and Management of Complications.

Maymone M, Venkatesh S, Laughter M, et al. Journal of the American Academy of Dermatology. 2020;

Publication

[Acceptability of chemoprophylaxis in an endemic area for leprosy: the PEP-Hans Brazil Project].

Cortela D, Ferreira S, Virmond M, et al. Cadernos de saude publica. 2020; 36 (3) : e00068719.
Download PDF

Publication

Preventing Leprosy: Epidemiological and immunological aspects of chemo- and immunoprophylaxis in leprosy patients’ contacts

Richardus R. Leiden University. Leiden University of Medical Center. 2020;
Download PDF

Publication

Reply to: Single-dose rifampicin and BCG to prevent leprosy.

Richardus JH, Geluk A. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;
Download PDF

Publication

Single-dose rifampicin and BCG to prevent leprosy.

Lockwood DN, De Barros B, Walker SL. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;
Download PDF

Publication

Prevention of transmission of leprosy: The current scenario.

Palit A, Kar H. Indian journal of dermatology, venereology and leprology. 2020; 86 (2) : 115-123.
Download PDF

Publication

Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts

Ortuno-Gutierrez N, Younoussa A, Randrianantoandro A, et al. Springer Science and Business Media LLC. BMC Infectious Diseases. 2019;
Download PDF

Publication

Leprosy post-exposure prophylaxis with single-dose rifampicin: toolkit for implementation

Barth-Jaeggi T, Cavaliero A, Aerts A. Leprosy review. 2019; 90 (4) : 356–363.
Download PDF

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page Next ›
  • Last page Last »

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • About Infolep
  • Privacy statement
  • FAQ
  • Contact

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2021 Infolep